FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS-INFECTION AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SERONEGATIVE AND TYPE-1-SEROPOSITIVE WOMEN FROMAN URBAN MINORITY COMMUNITY
Lm. Clarke et al., FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS-INFECTION AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SERONEGATIVE AND TYPE-1-SEROPOSITIVE WOMEN FROMAN URBAN MINORITY COMMUNITY, The Journal of infectious diseases, 173(1), 1996, pp. 77-82
Cytomegalovirus (CMV) seroprevalence and genital tract shedding in hum
an immunodeficiency virus (HIV)-seronegative and HIV-seropositive wome
n from an urban minority community were investigated. CMV seropositivi
ty was high in both groups: 181 (95.2%) of 190 HIV-negative and 158 (9
0.3%) of 175 HIV-positive subjects. Cervicovaginal shedding was detect
ed in 8 (4.4%) CMV-positive HIV-negative subjects and 31 (19.6%) HIV-p
ositive subjects (odds ratio [OR], 5.28; P < .001), Multiple logistic
regression analysis revealed that CMV shedding was independently assoc
iated with younger age (OR = 0.90; P < .001) and concurrent Chlamydia
trachomatis or Neisseria gonorrhoeae infection (OR = 3.60; P = .08). H
owever, shedding was observed over a broad age range in HIV-positive s
ubjects, with 54.8% of shedders being greater than or equal to 30 year
s old. Among HIV-positive subjects, CMV shedding was also associated w
ith decreased CD4 cell counts (P = .04) and, compared with HIV-negativ
e subjects, was significantly higher (P < .001) among subjects with CD
4 cell counts <500 X 10(6)/L (26.5% in subjects with counts less than
or equal to 200 and 22.1% in subjects with counts of 201-499 X 10(6)/L
).